Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome
Familial Cancer · 2024
DOI: 10.1007/s10689-024-00419-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Familial Cancer, 2024. Verfasst von Claire Freycon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology-Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada. clair…. Hauptthemen laut MEDLINE: Li-Fraumeni Syndrome, Tumor Suppressor Protein p53, Germ-Line Mutation, Pedigree. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: CIHR, Fondation ARC pour la Recherche sur le Cancer, Canceropole Lyon Auvergne Rhone-Alpes.
Abstract (Originalsprache)
Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with germline pathogenic/likely pathogenic variants in TP53. Genotype-phenotype correlations are progressively being characterized in LFS with certain TP53 variants associated with attenuated penetrance and phenotypes. We report on a family harboring a TP53 p.R181H variant presenting with a restricted cancer phenotype in adulthood. The proband was a female with breast cancer at the age of 71 years who had three first degree relatives also diagnosed with breast cancer after the age of 40 years (mother, two sisters). Of the nine individuals harboring the variant (6 genetically confirmed, 3 obligate heterozygous), six have not developed malignancies at this time (age range: 36-42). No childhood-onset cancers were reported in this family. A concomitant literature review identified 51 additional individuals harboring the p.R181H variant in TP53, presenting a tumor phenotype dominated by breast cancer. Rare occurrences of other adult-onset cancers (prostate, colorectal and thyroid) and only few childhood onset cancer were documented. These observations are consistent with functional analysis showing that p.R181H retains partial p53 function and suggesting possible reduced cancer penetrance, particularly in the pediatric setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Hematology-Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada. claire.freycon@muhc.mcgill.ca.
- Department of Child Health and Human Development, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. claire.freycon@muhc.mcgill.ca.
- Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, QC, Canada.
- Department of Human Genetics, McGill University, Montreal, QC, Canada.
- Department of Child Health and Human Development, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- Core Molecular Diagnostic Laboratory, McGill University Health Centre, Montreal, QC, Canada.
ORCID-Profile: Claire Freycon
Förderung
- CIHR
- Fondation ARC pour la Recherche sur le Cancer
- Canceropole Lyon Auvergne Rhone-Alpes
- Fonds de Recherche du Québec - Santé
- Fondation de l’Hôpital de Montréal pour enfants
- Cole Foundation
- TD Ready Challenge
- Fondation du cancer des Cèdres
Zitieren
APA
Freycon, C., Palma, L., Budd, C., Coulombe, F., Witkowski, L., Hainaut, P., Foulkes, W. D., & Goudie, C. (2024). Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome. Familial Cancer. https://doi.org/10.1007/s10689-024-00419-7
Vancouver
Freycon C, Palma L, Budd C, Coulombe F, Witkowski L, Hainaut P, et al. Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome. Familial Cancer. 2024. doi:10.1007/s10689-024-00419-7
BibTeX
@article{Freycon2024,
author = {Freycon, Claire and Palma, Laura and Budd, Crystal and Coulombe, Frederic and Witkowski, Leora and Hainaut, Pierre and Foulkes, William D and Goudie, Catherine},
title = {Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome},
journal = {Familial Cancer},
year = {2024},
doi = {10.1007/s10689-024-00419-7}
}
EUVIMED